Rheumatology Research Foundation | Grant Review Committee | 2021 - Present |
Arthritis Foundation | Osteoarthritis Clinical Trials Network | 2021 - Present |
Arthritis Foundation | Osteoarthritis Grant Reviews | 2019 - 2021 |
American College of Rheumatology | Guidelines Committee for Osteoarthritis | 2017 - 2020 |
Training Oversight Committee CTSI | Director | 2015 - Present |
Operations Management Team, CTSI | Member | 2015 - Present |
Boston University KL2 Program | Director | 2015 - Present |
Editorial Board, Arthritis and Rheumatology Co-Editor | Editor | 2015 - Present |
PCORI | Review panel for pragmatic trials | 2014 - Present |
Boston Department of Medicine | Geriatric Search Committee | 2013 - 2016 |
Boston Hospital Department of Medicine | Appointments and Promotions Committee | 2012 - 2019 |
Zimmer Knee Creations | Consultant | 2011 - 2016 |
Arthritis Foundation | Osteoarthritis Grant Reviews | 2011 - 2014 |
American College of Rheumatology | Classification and Response Criteria Committee | 2009 - 2012 |
Arthritis Foundation | National Grants Committee | 2008 - Present |
Commonwealth of Massachusetts | Member | 2006 - 2014 |
American College of Rheumatology | Classification and Response Criteria Subcommittee | 2004 - 2008 |
American College of Rheumatology | Abstract Selection Committee, Epidemiology and Health Services Research | 2004 - 2005 |
American College of Rheumatology | ACR Committee to Reevaluate Improvement Criteria in Rheumatoid Arthritis | 2003 - 2005 |
U.S. Food and Drug Administration | Arthritis Advisory Committee | 2003 - Present |
American Board of Internal Medicine | Committee on Practice Management in Osteoarthritis (representing American College of Physicians) | 2001 - 2002 |
Journal of Rheumatology Editorial Board, Journal of Rheumatology | Member | 1998 - 2013 |
American Journal of Medicine, American Journal of Medicine | Member | 1998 - 2011 |
Data Safety Monitoring Board | Alexion Anti-C5 trial in rheumatoid arthritis | 1997 - 2003 |
Data Safety Monitoring Board | ATTRACT trial (use of anti-TNF in rheumatoid arthritis, Centocor) | 1997 - 2000 |
U.S. Food and Drug Administration | Arthritis Advisory Committee | 1997 - 2002 |
Boston Hospital Department of Medicine | Research Planning committee | 1997 - 1998 |
Editorial Board, Osteoarthritis and Cartilage | Member | 1997 - Present |
Boston Medical Center Department of Medicine Quality Improvement | Chair | 1995 - 1997 |
Editorial Board, Arthritis Care Research | Member | 1994 - 2010 |
Arthritis Foundation | Research Committee | 1994 - 1995 |
American College of Rheumatology | Manpower Committee | 1994 |
American College of Rheumatology | Abstract Selection Committee, Epidemiology/Health Services Research Abstracts | 1993 |
Boston City Hospital Department of Medicine Quality Improvement Committee | Chair | 1991 - 1995 |
American College of Rheumatology | Committee on Outcome Measures for Rheumatoid Arthritis Trials | 1991 - 1994 |
American College of Rheumatology | Committee on Health Care Research | 1990 - 1995 |
American College of Rheumatology | Manpower Committee | 1990 |
Framingham Heart Study Research Committee | Member | 1990 - Present |
Editorial Board, Arthritis and Rheumatism | Board Member | 1989 - 1993 |
Arthritis Foundation | Grants Subcommittee of the A.F. Research Committee | 1988 - 1990 |
American College of Rheumatology | Abstract Selection Committee, Epidemiology/Health Services Research Abstracts, | 1988 |
National Arthritis Advisory US Government | Consultant | 1987 - Present |